Literature DB >> 30692063

[Response inhibition and emotional responding in attention-deficit/hyperactivity disorder with comorbid disruptive, impulse-control, and conduct disorders].

Xixi Jiang1, Li Liu1, Haifeng Ji1, Ju Gao1, Minmin Zhang1, Yuncheng Zhu2, Kaiyun Li3, Weidong Ji1, Guohai Li4.   

Abstract

OBJECTIVE: To characterize the traits of neuropsychological functioning deficits in patients with attention-deficit/ hyperactivity disorder (ADHD) with comorbid disruptive, impulse-control, and conduct disorders (DICCD).
METHODS: Twenty out-patients with ADHD, 20 with ADHD with comorbid DICCD, and 20 with DICCD, all aged 6-16 years, were enrolled in this study, with 20 healthy subjects matched for age, gender and IQ serving as the healthy controls. The patients were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Revision (DSM-5). All the subjects were assessed with Golden Stroop test and emotional Stroop test to evaluate their response inhibition and emotional responding.
RESULTS: In Golden Stroop test, the interference scores (IGs) of errors and reaction time both differed significantly among the groups (P < 0.05), and were the highest in patients with ADHD only. In emotional Stroop test, the mean reaction time (MRT) showed significant differences among the groups (P < 0.05); the MRT of positive- congruent trials in ADHD with comorbid DICCD group was shorter than that in ADHD group but longer than that in group DICCD; the MRT in the 3 case groups were all longer than that in the control group. The MRT of both positive-incongruent trials and negative-congruent trials in ADHD with comorbid DICCD group and DICCD group was shorter than that in ADHD group but longer than that in the control group. The MRT of negative- incongruent trials in DICCD group was shorter than that in ADHD group and ADHD with comorbid DICCD group but longer than that in the control group.
CONCLUSIONS: The response inhibition deficit and abnormal emotional responding are the core symptoms of ADHD. Bias emotional stimuli may render response inhibitory dysfunction in patients with DICCD with callous-unemotional traits of emotional responding disorder, especially in dealing with negative emotional trials, while the comorbidity of ADHD and DICCD tends to have the emotional response trait of DICCD.

Entities:  

Keywords:  Stroop effect; attention-deficit/hyperactivity disorder; disruptive, impulse-control, and conduct disorders; neural networks; response inhibition

Mesh:

Year:  2019        PMID: 30692063      PMCID: PMC6765569          DOI: 10.12122/j.issn.1673-4254.2019.01.05

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  19 in total

Review 1.  Neuro-cognitive system dysfunction and symptom sets: A review of fMRI studies in youth with conduct problems.

Authors:  R J R Blair; K Veroude; J K Buitelaar
Journal:  Neurosci Biobehav Rev       Date:  2016-10-26       Impact factor: 8.989

2.  Comorbidity prevalence and treatment outcome in children and adolescents with ADHD.

Authors:  Laura Reale; Beatrice Bartoli; Massimo Cartabia; Michele Zanetti; Maria Antonella Costantino; Maria Paola Canevini; Cristiano Termine; Maurizio Bonati
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-05-19       Impact factor: 4.785

Review 3.  Computational psychiatry.

Authors:  Xiao-Jing Wang; John H Krystal
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

4.  Heritability of brain activity related to response inhibition: A longitudinal genetic study in adolescent twins.

Authors:  Andrey P Anokhin; Simon Golosheykin; Julia D Grant; Andrew C Heath
Journal:  Int J Psychophysiol       Date:  2017-03-12       Impact factor: 2.997

5.  Neural mechanisms underlying cognitive control of men with lifelong antisocial behavior.

Authors:  Boris Schiffer; Christina Pawliczek; Bernhard Mu Ller; Michael Forsting; Elke Gizewski; Norbert Leygraf; Sheilagh Hodgins
Journal:  Psychiatry Res       Date:  2014-01-28       Impact factor: 3.222

Review 6.  Computational Psychiatry of ADHD: Neural Gain Impairments across Marrian Levels of Analysis.

Authors:  Tobias U Hauser; Vincenzo G Fiore; Michael Moutoussis; Raymond J Dolan
Journal:  Trends Neurosci       Date:  2016-01-17       Impact factor: 13.837

Review 7.  Prevalence of attention deficit/hyperactivity disorder among children and adolescents in China: a systematic review and meta-analysis.

Authors:  Tingting Wang; Kaihua Liu; Zhanzhan Li; Yang Xu; Yuan Liu; Wenpei Shi; Lizhang Chen
Journal:  BMC Psychiatry       Date:  2017-01-19       Impact factor: 3.630

8.  Hot and Cool Executive Functions in Adolescence: Development and Contributions to Important Developmental Outcomes.

Authors:  Kean Poon
Journal:  Front Psychol       Date:  2018-01-10

Review 9.  The Relationship between Neurocircuitry Dysfunctions and Attention Deficit Hyperactivity Disorder: A Review.

Authors:  Yuncheng Zhu; Daoliang Yang; Weidong Ji; Tianming Huang; Lianxue Xue; Xixi Jiang; Liangliang Chen; Fang Wang
Journal:  Biomed Res Int       Date:  2016-09-01       Impact factor: 3.411

10.  Clinician ratings of the Comprehensive Assessment of Psychopathic Personality (CAPP) in a representative sample of Spanish prison inmates: New validity evidence.

Authors:  Gerardo Flórez; Ventura Ferrer; Luis S García; María R Crespo; Manuel Pérez; Pilar A Saíz; David J Cooke
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

View more
  2 in total

1.  Response Inhibition and Emotional Regulation in the Patients with Attention-Deficit/Hyperactivity Disorder and Comorbidity of Disruptive, Impulse-Control, and Conduct Disorders.

Authors:  Xixi Jiang; Yuncheng Zhu; Yiru Fang
Journal:  Psychiatry Investig       Date:  2019-11-15       Impact factor: 2.505

2.  Cognitive control and emotional response in attention-deficit/ hyperactivity disorder comorbidity with disruptive, impulse-control, and conduct disorders.

Authors:  Yuncheng Zhu; Li Liu; Daoliang Yang; Haifeng Ji; Tianming Huang; Lianxue Xue; Xixi Jiang; Kaiyun Li; Lily Tao; Qing Cai; Yiru Fang
Journal:  BMC Psychiatry       Date:  2021-05-04       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.